# Diabetic Nephropathy Market to Generate Profitable Avenues for Existing Companies as Well as New Players
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-29
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Global Diabetic Nephropathy Market Growth Analysis 2020
Meta Description: Discover the latest insights on the diabetic nephropathy market, including growth projections, key players, and regional trends. Get a sample copy of the
URL: https://financedigest.com/diabetic-nephropathy-market-to-generate-profitable-avenues-for-existing-companies-as-well-as-new-playershtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836827399-compressed.jpg)

According to a new market report published by Persistence Market Research “ **Global Market Study on Diabetic Nephropathy Market – Asia to Witness Highest Growth by 2020**,”.The global diabetic nephropathy market was valued at **USD 2,262.2 million** in 2014 and is expected to grow at a **CAGR of 5.6%** from 2014 to 2020, to reach an expected value of **USD 3,145.9 million** in 2020.

[Diabetic nephropathy](https://www.persistencemarketresearch.com/market-research/diabetic-nephropathy-market.asp) is a disease of the kidney glomerulus and one of the most significant complications in terms of mortality and morbidity for patients with diabetes. Globally, the diabetic nephropathy [market is witnessing](https://www.financedigest.com/the-underwear-market-to-witness-calculated-innovation.html "The Underwear Market To Witness Calculated Innovation") significant growth due to increasing prevalence of diabetes and obesity in different regions of the world.

**Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/3594**](https://www.persistencemarketresearch.com/samples/3594)

In addition, increasing R&D [investments in drug discovery and development and raising](https://www.financedigest.com/5-tips-for-raising-investment-as-a-start-up.html "5 tips for raising investment as a start-up") awareness about diabetes and kidney-related disorders are also driving the growth of the market. However, stringent regulatory requirements and longer approval time for drugs as well as the lack of comprehensive therapeutic management for diabetic nephropathy are inhibiting the [growth of diabetic nephropathy market](https://www.financedigest.com/agar-market-is-set-to-experience-revolutionary-growth-by-2026.html "Agar Market Is Set to Experience Revolutionary Growth by 2026").

In North America, various [government programs are spreading awareness](https://www.financedigest.com/the-network-group-events-calls-on-the-government-to-invest-in-public-awareness-campaign-around-cyber-security.html "The Network Group Events calls on the Government to invest in public awareness campaign around cyber security") about diabetes and related renal complications. For instance, the National Kidney Disease Education Program, one of the major programs organized by the U.S. government, for [increasing awareness about the various kidney diseases](https://www.financedigest.com/growing-burden-of-periodontal-diseases-to-increase-mouthwash-usage.html "Growing Burden of Periodontal Diseases to Increase Mouthwash Usage"). In addition, the number of diabetic patients are also increasing in the region; according to the SciELO Public Health, approximately 35 million people were affected with diabetes mellitus in 2000 and this number is [expected to reach](https://www.financedigest.com/wind-turbine-generator-market-is-expected-to-reach-net-valuation-of-more-than-us-90-7bn-during-forecast-period-of-2021-to-2031.html "Wind Turbine Generator Market Is Expected To Reach Net Valuation Of More Than US$ 90.7Bn During Forecast Period Of 2021 To 2031") 64 million by 2025 in North America.

**Get a Customized Scope to Match Your Need Ask an Expert-** [**sales@persistencemarketresearch.com**](mailto:sales@persistencemarketresearch.com)

In Europe, rise in healthcare expenditure for diabetes treatment and increasing prevalence of diabetes in the various part of Europe is [boosting the growth of the European](https://www.financedigest.com/energy-stocks-boost-european-shares-ahead-of-ecb-minutes.html "Energy stocks boost European shares ahead of ECB minutes") diabetic nephropathy market. According to IDF, approximately 55.4 million people had diabetes in 2010 and the number is [expected to reach](https://www.financedigest.com/warewashing-professional-equipment-market-expected-to-reach-us-6-94-bn-by-2027-tmr-study.html "Warewashing Professional Equipment Market Expected To Reach US$ 6.94 Bn By 2027 – TMR Study") 66.5 million by 2030 in Europe. According to the IDF, healthcare expenditure for diabetes treatment was approximately USD 105.5 billion in 2010 and is [expected](https://www.financedigest.com/factbox-big-banks-expected-to-rack-up-more-than-1-billion-in-fines-for-whatsapp-use.html "Factbox-Big banks expected to rack up more than  billion in fines for WhatsApp use") to reach USD 124.6 billion by 2030 in Europe.

Asia represents the fastest growing region in the diabetic nephropathy [market due to the rise](https://www.financedigest.com/ott-content-market-to-rise-to-a-valuation-of-us-245814-4-mn.html "OTT Content Market to rise to a valuation of US$ 245,814.4 Mn") in a diabetic population in various countries such as Japan and the Southeast Asian countries. According to the International Diabetes Federation (IDF), [developing countries](https://www.financedigest.com/what-its-like-for-women-entrepreneurs-in-developing-countries.html "What it’s Like for Women Entrepreneurs in Developing Countries"), such as India and China, are expected to have the highest number of diabetes mellitus patients compared to developed countries, such as the U.S. and Germany.

Sanofi is one of the leading [players in the diabetic nephropathy market](https://www.financedigest.com/poultry-diagnostics-market-players-look-to-capitalize-on-low-costs-and-high-accuracy-of-elisa-fmi-study.html "Poultry Diagnostics Market Players Look to Capitalize on Low Costs and High Accuracy of ELISA: FMI Study"). Other major [players in diabetic nephropathy market](https://www.financedigest.com/colloidal-alumina-market-industry-analysis-type-and-application-key-players-regions-forecast-by-2031.html "Colloidal Alumina Market Industry Analysis, Type and Application, Key Players, Regions, Forecast by 2031") include Eli Lilly and Company, Mitsubishi Tanabe Pharma Corporation, Novartis AG, Pfizer, Inc., Abbott Laboratories, AbbVie, Inc., Bayer AG, Merck & Co., Inc., Bayer AG and Reata Pharmaceuticals, Inc.

**Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/3594**](https://www.persistencemarketresearch.com/checkout/3594)

**Read More Trending “PMR Exclusive Article”-**

**Single Use Bioprocess System Market**– [Single Use Bioprocess System Market](https://www.persistencemarketresearch.com/market-research/single-use-bioprocess-system-market.asp) Segmented By Bioreactors, Mixers, Bioprocess Containers, Transfer and Storage Bags, Sampling Systems, Filtration Systems, Chromatography Columns, Probes & Sensors, Tubing Assemblies, Connectors & Clamps, Filling Systems Components

**Nocturia market**-The [Nocturia market](https://www.persistencemarketresearch.com/market-research/nocturia-market.asp) is segmented by the indication that is Mixed nocturia, Low nocturnal bladder capacity, Nocturnal polyuria, Global polyuria, and by drug type that are Anticholinergic drugs, Desmopressin, Antibiotics, Antispasmodic.

**About Us: –** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact us:**

**[Persistence Market](https://www.financedigest.com/persistence-innovation-to-replenish-the-novel-sweeteners-market.html "Persistence Innovation To Replenish The Novel Sweeteners Market") Research**

Address – 305 Broadway, 7th FloorNew [York City](https://www.financedigest.com/dr-letao-qin-joins-rimon-as-partner-in-its-research-triangle-park-and-new-york-city-offices.html "Dr.Letao Qin, joins Rimon as Partner in its Research Triangle Park and New York City Offices"),

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Sales** – sales@persistencemarketresearch.com

**Website** – https://www.persistencemarketresearch.com


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---

